Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic
Frontiers in Pediatrics · 15.10.2025 · 13
DOI: 10.3389/fped.2025.1640747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 15.10.2025. Verfasst von Dina Kamel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Long COVID describes the persistence or recurrence of symptoms beyond the acute phase of SARS-CoV-2 infection and is increasingly recognized in children and adolescents. Despite its prevalence, understanding of symptom patterns and the influence of vaccination on disease trajectory in pediatric populations remains limited.
Methods
We conducted a retrospective study of patients aged 0–21 years evaluated at the Long COVID Clinic at Children's Hospital Los Angeles between August 2021 and November 2023. Patients were included if they reported persistent or new symptoms ≥4 weeks after SARS-CoV-2 infection.
Results
A total of 123 patients were enrolled. The mean age was 13.1 years, and 51% were male. Symptom onset occurred a mean of 5 weeks after infection. At presentation, 56% of patients reported symptoms lasting 0–24 weeks, 28% for 25–52 weeks, and 16% for >52 weeks. Fatigue (93%) and headache (70%) were the most prevalent symptoms in both younger (<12 years) and older (>12 years) cohorts. Female patients more frequently reported brain fog, dizziness, palpitations, and postural orthostatic tachycardia syndrome. Overall symptom burden decreased significantly over time ( p < 0.001). Vaccination status at baseline was not associated with difference in symptom duration on initial presentation ( p = 0.4). However, among those vaccinated after developing long COVID, 41% reported subjective improvement in the following weeks.
Conclusion
Pediatric long COVID is marked by prolonged, multisystem symptoms. Vaccination may offer symptomatic benefit for some patients, though larger prospective studies are necessary to better define its role.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Infectious Diseases, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA, United States.
- Department of Pediatrics, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA, United States.
- Biostatistics and Data Management Core, The Saban Research Institute, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA, United States.
- Department of Radiology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, CA, United States.
Zitieren
APA
Kamel, D., Vu, M. H., Bender, J., Warburton, D., Wood, J. C., & Mohandas, S. (2025). Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic. Frontiers in Pediatrics, 13. https://doi.org/10.3389/fped.2025.1640747
Vancouver
Kamel D, Vu MH, Bender J, Warburton D, Wood JC, Mohandas S. Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic. Frontiers in Pediatrics. 2025;13. doi:10.3389/fped.2025.1640747
BibTeX
@article{Kamel2025,
author = {Kamel, Dina and Vu, My H and Bender, Jeffery and Warburton, David and Wood, John C and Mohandas, Sindhu},
title = {Exploring long COVID in pediatric patients: clinical insights from a long COVID clinic},
journal = {Frontiers in Pediatrics},
year = {2025},
volume = {13},
doi = {10.3389/fped.2025.1640747}
}
EUVIMED